<DOC>
	<DOCNO>NCT00370734</DOCNO>
	<brief_summary>In active phase thyroid eye disease patient obvious upper lid retraction , sometimes exposure keratopathy .To date standard treatment situation . We go compare natural course upper lid retraction injection botulinum toxin A injection upper lid percutaneously .</brief_summary>
	<brief_title>Effect Percutaneous Botulinum Toxin A Injection Natural Course Upper Lid Retraction Thyroid Eye Disease</brief_title>
	<detailed_description />
	<mesh_term>Eye Diseases</mesh_term>
	<mesh_term>Graves Ophthalmopathy</mesh_term>
	<mesh_term>Botulinum Toxins , Type A</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins</mesh_term>
	<criteria>patient wiht oper lid retraction active phase thyroid ophthalmopathy patient non active phase</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2007</verification_date>
	<keyword>botulinum toxin</keyword>
	<keyword>thyroid eye disease</keyword>
	<keyword>lid retraction</keyword>
</DOC>